Quercetin in Animal Models of Alzheimer’s Disease: A Systematic Review of Preclinical Studies

Alzheimer’s disease (AD) is the leading cause of dementia worldwide. It involves progressive impairment of cognitive function. A growing number of neuroprotective compounds have been identified with potential anti-AD properties through in vitro and in vivo models of AD. Quercetin, a natura...

Full description

Bibliographic Details
Main Authors: Xiao-Wen Zhang, Jia-Yue Chen, Defang Ouyang, Jia-Hong Lu
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/2/493
id doaj-a9fc4645a5734cbb8bd1e4f54a2a3397
record_format Article
spelling doaj-a9fc4645a5734cbb8bd1e4f54a2a33972020-11-25T01:27:39ZengMDPI AGInternational Journal of Molecular Sciences1422-00672020-01-0121249310.3390/ijms21020493ijms21020493Quercetin in Animal Models of Alzheimer’s Disease: A Systematic Review of Preclinical StudiesXiao-Wen Zhang0Jia-Yue Chen1Defang Ouyang2Jia-Hong Lu3State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, MacaoState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, MacaoState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, MacaoState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, MacaoAlzheimer’s disease (AD) is the leading cause of dementia worldwide. It involves progressive impairment of cognitive function. A growing number of neuroprotective compounds have been identified with potential anti-AD properties through in vitro and in vivo models of AD. Quercetin, a natural flavonoid contained in a wide range of plant species, is repeatedly reported to exert neuroprotective effects in experimental animal AD models. However, a systematic analysis of methodological rigor and the comparison between different studies is still lacking. A systematic review uses a methodical approach to minimize the bias in each independent study, providing a less biased, comprehensive understanding of research findings and an objective judgement of the strength of evidence and the reliability of conclusions. In this review, we identified 14 studies describing the therapeutic efficacy of quercetin on animal AD models by electronic and manual retrieval. Some of the results of the studies included were meta-analyzed by forest plot, and the methodological quality of each preclinical trial was assessed with SYRCLE’s risk of bias tool. Our results demonstrated the consistent neuroprotective effects of quercetin on different AD models, and the pharmacological mechanisms of quercetin on AD models are summarized. This information eliminated the bias of each individual study, providing guidance for future tests and supporting evidence for further implementation of quercetin into clinical trials. However, the limitations of some studies, such as the absence of sample size calculations and low method quality, should also be noted.https://www.mdpi.com/1422-0067/21/2/493alzheimer’s diseasequercetinneuroprotective effectsanimal ad models
collection DOAJ
language English
format Article
sources DOAJ
author Xiao-Wen Zhang
Jia-Yue Chen
Defang Ouyang
Jia-Hong Lu
spellingShingle Xiao-Wen Zhang
Jia-Yue Chen
Defang Ouyang
Jia-Hong Lu
Quercetin in Animal Models of Alzheimer’s Disease: A Systematic Review of Preclinical Studies
International Journal of Molecular Sciences
alzheimer’s disease
quercetin
neuroprotective effects
animal ad models
author_facet Xiao-Wen Zhang
Jia-Yue Chen
Defang Ouyang
Jia-Hong Lu
author_sort Xiao-Wen Zhang
title Quercetin in Animal Models of Alzheimer’s Disease: A Systematic Review of Preclinical Studies
title_short Quercetin in Animal Models of Alzheimer’s Disease: A Systematic Review of Preclinical Studies
title_full Quercetin in Animal Models of Alzheimer’s Disease: A Systematic Review of Preclinical Studies
title_fullStr Quercetin in Animal Models of Alzheimer’s Disease: A Systematic Review of Preclinical Studies
title_full_unstemmed Quercetin in Animal Models of Alzheimer’s Disease: A Systematic Review of Preclinical Studies
title_sort quercetin in animal models of alzheimer’s disease: a systematic review of preclinical studies
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2020-01-01
description Alzheimer’s disease (AD) is the leading cause of dementia worldwide. It involves progressive impairment of cognitive function. A growing number of neuroprotective compounds have been identified with potential anti-AD properties through in vitro and in vivo models of AD. Quercetin, a natural flavonoid contained in a wide range of plant species, is repeatedly reported to exert neuroprotective effects in experimental animal AD models. However, a systematic analysis of methodological rigor and the comparison between different studies is still lacking. A systematic review uses a methodical approach to minimize the bias in each independent study, providing a less biased, comprehensive understanding of research findings and an objective judgement of the strength of evidence and the reliability of conclusions. In this review, we identified 14 studies describing the therapeutic efficacy of quercetin on animal AD models by electronic and manual retrieval. Some of the results of the studies included were meta-analyzed by forest plot, and the methodological quality of each preclinical trial was assessed with SYRCLE’s risk of bias tool. Our results demonstrated the consistent neuroprotective effects of quercetin on different AD models, and the pharmacological mechanisms of quercetin on AD models are summarized. This information eliminated the bias of each individual study, providing guidance for future tests and supporting evidence for further implementation of quercetin into clinical trials. However, the limitations of some studies, such as the absence of sample size calculations and low method quality, should also be noted.
topic alzheimer’s disease
quercetin
neuroprotective effects
animal ad models
url https://www.mdpi.com/1422-0067/21/2/493
work_keys_str_mv AT xiaowenzhang quercetininanimalmodelsofalzheimersdiseaseasystematicreviewofpreclinicalstudies
AT jiayuechen quercetininanimalmodelsofalzheimersdiseaseasystematicreviewofpreclinicalstudies
AT defangouyang quercetininanimalmodelsofalzheimersdiseaseasystematicreviewofpreclinicalstudies
AT jiahonglu quercetininanimalmodelsofalzheimersdiseaseasystematicreviewofpreclinicalstudies
_version_ 1725103905083228160